Cinqair
RxNorm 1746894
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1746894 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cinqair.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
BNPrescribable
Brand Name (BN):
Cinqair
(Atom ID: 7751125)
Patient Education
Reslizumab Injection
Reslizumab injection is used along with other medications to treat asthma in certain people. Reslizumab is in a class of medications called monoclonal antibodies. It works by reducing a certain type of white blood cell that may contribute to your asthma.
[Learn More]
* Please review the disclaimer below.